The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Otulipenia: From Inflammatory Case Studies to Treatment

Otulipenia: From Inflammatory Case Studies to Treatment

October 24, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Gio.tto_Shutterstock_DNASequence_500x270A growing body of research indicates the ubiquitin pathway is important in the pathophysiology of many different human diseases. For example, haploinsufficiency of A20 (HA20) results from a germline mutation causing dysregulated ubiquitination and an inflammatory phenotype. In their latest research, Qing Zhou, PhD, a research fellow at the National Human Genome Research Institute in Bethesda, Md., and colleagues describe a second human inflammatory disease, otulipenia, caused by germline mutations that leads to dysregulated ubiquitination. Their results were published Aug. 24 in the Proceedings of the National Academy of Sciences.1

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: Research Lends Insight Into Osteoporosis Treatment, New Auto-Inflammatory Disease, Scleroderma
  • Interleukin 1-alpha Is Critical for Establishment of Inflammatory Lung Disease
  • Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
Also By This Author
  • Lupus Treatments: Into the Future

The team of researchers identified three unrelated patients from Turkey and Pakistan who had a similar phenotype of pronounced inflammation: Patient 1 was born prematurely and soon developed a fever and rash. Patient 2 presented at the age of 4.5 months with prolonged fevers and pustular, scarring rashes. Patient 3 presented with neonatal onset fever, as well as prominent cutaneous lesions, such as an erythematous rash with painful skin nodules. The patients all had increased serum levels of proinflammatory cytokines. The investigators used exome sequencing and candidate gene screening to identify three different loss-of-function mutations in the OTULIN/FAM105B gene.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

OTULIN acts as a Met1-specific deubiquitinase that removes linear polyubiquitin chains. OTULIN also has a role in the regulation of Wnt and innate immune signaling complexes. Specifically, it attenuates inflammatory signals in the NF-ҡB and ASC-mediated pathways via hydrolysis of Met1-linked ubiquitin chains. Although the patients in the current study had impaired deubiquitinase and inflammation, previous research has revealed that patients who have the opposite situation (impaired linear ubiquination) have the opposite clinical presentation (immunodeficiency). Patients with impaired ubiquination are diagnosed as having linear ubiquitin assembly complex (LUBAC) deficiency.

Previous research has shown that OTULIN restricts NF-ҡB signaling activity, so these scientists performed in vitro experiments to evaluate the immunological response of the patients’ cells. They found that when they stimulated the patients’ fibroblasts and peripheral blood mononuclear cells with TNF or IL-1β the cells responded with increased signaling in the canonical NF-ҡB pathway and secreted increased levels of proinflammatory cytokines (relative to healthy controls).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We describe a recessively inherited autoinflammatory disease caused by excessive linear ubiquitination in innate immune signaling  pathways, which we denote as ‘otulipenia,’” write the authors in their discussion. “We show that OTULIN deficiency leads to increased linear ubiquitination of target proteins, which is associated with enhanced NF-κB activity, increased TNFR1 signaling, and NLRP3 inflammasome activity. The phenotype is very severe and potentially lethal if left untreated.”

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: genetic, genetic mutation, germline mutation, inflammation, otulipenia, ubiquitin pathway

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: Research Lends Insight Into Osteoporosis Treatment, New Auto-Inflammatory Disease, Scleroderma
  • Interleukin 1-alpha Is Critical for Establishment of Inflammatory Lung Disease
  • Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
  • 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.